Variable | Leprosy patients (N = 15), n (%) |
---|---|
Age (years) | |
Range | 5–74 |
Median | 23 |
Gender | |
Male | 9 (60) |
Female | 6 (40) |
Country of origin | |
Philippines | 3 (20) |
Cambodia | 3 (20) |
India | 3 (20) |
Pakistan | 1 (7) |
Cameroon | 1 (7) |
Tanzania | 1 (7) |
Thailand | 1 (7) |
Sri Lanka | 2 (13) |
Duration of stay in Denmark (years) | |
Range | 0–20 |
Median | 0 |
0–5 | 11 (73) |
≤6–10 | 0 |
≤11–15 | 0 |
≤16–20 | 1 (7) |
Unknown | 3 (20) |
Duration of clinical presentation (weeks) | |
Range | 3–384 |
Median | 36 |
Classification | |
Tuberculoid leprosy (TT) | 5 (33) |
Borderline tuberculoid leprosy (BT)/Borderline leprosy (BB)/Borderline lepromatous leprosy (BL) | 8 (53) |
Lepromatous leprosy (LL) | 1 (7) |
Indeterminate leprosy | 1 (7) |
Reactions | |
Type 1 | 4 (27) |
Type 2 | 2 (13) |
Histopathological findings | |
Skin smears positive for bacilli (7 patients had skin smears performed) | 3 (43) |
Granulomas in biopsies | 9 (60) |